Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)
CNY 10.62
(1.63%)
CNY 10.62
(1.63%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.45 Billion CNY | 11.83% |
| 2022 | 5.77 Billion CNY | 17.82% |
| 2021 | 4.9 Billion CNY | 2.64% |
| 2020 | 4.77 Billion CNY | -13.27% |
| 2019 | 5.5 Billion CNY | 5.0% |
| 2018 | 5.24 Billion CNY | 7.99% |
| 2017 | 4.85 Billion CNY | 14.93% |
| 2016 | 4.22 Billion CNY | 26.74% |
| 2015 | 3.33 Billion CNY | 44.56% |
| 2014 | 2.3 Billion CNY | 16.43% |
| 2013 | 1.98 Billion CNY | 14.04% |
| 2012 | 1.73 Billion CNY | 10.66% |
| 2011 | 1.56 Billion CNY | 5.91% |
| 2010 | 1.48 Billion CNY | 5.6% |
| 2009 | 1.4 Billion CNY | 345.7% |
| 2008 | 314.92 Million CNY | 5.77% |
| 2007 | 297.73 Million CNY | 2.09% |
| 2006 | 291.65 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 5.82 Billion CNY | 0.51% |
| 2024 Q2 | 5.79 Billion CNY | -6.99% |
| 2024 Q1 | 6.22 Billion CNY | -3.61% |
| 2023 Q4 | 6.45 Billion CNY | 0.57% |
| 2023 Q1 | 5.74 Billion CNY | -0.49% |
| 2023 FY | 6.45 Billion CNY | 11.83% |
| 2023 Q3 | 6.42 Billion CNY | 3.27% |
| 2023 Q2 | 6.21 Billion CNY | 8.2% |
| 2022 Q2 | 5.37 Billion CNY | 3.31% |
| 2022 Q1 | 5.19 Billion CNY | 6.05% |
| 2022 Q3 | 5.81 Billion CNY | 8.21% |
| 2022 FY | 5.77 Billion CNY | 17.82% |
| 2022 Q4 | 5.77 Billion CNY | -0.62% |
| 2021 Q4 | 4.9 Billion CNY | -2.3% |
| 2021 Q1 | 5 Billion CNY | 4.72% |
| 2021 FY | 4.9 Billion CNY | 2.64% |
| 2021 Q3 | 5.01 Billion CNY | -1.54% |
| 2021 Q2 | 5.09 Billion CNY | 1.88% |
| 2020 Q2 | 5.53 Billion CNY | -4.06% |
| 2020 Q4 | 4.77 Billion CNY | -14.91% |
| 2020 Q3 | 5.61 Billion CNY | 1.39% |
| 2020 Q1 | 5.77 Billion CNY | 4.79% |
| 2020 FY | 4.77 Billion CNY | -13.27% |
| 2019 Q4 | 5.5 Billion CNY | 2.59% |
| 2019 FY | 5.5 Billion CNY | 5.0% |
| 2019 Q3 | 5.36 Billion CNY | -5.8% |
| 2019 Q2 | 5.69 Billion CNY | -1.92% |
| 2019 Q1 | 5.8 Billion CNY | 10.78% |
| 2018 Q3 | 5.18 Billion CNY | 6.37% |
| 2018 Q4 | 5.24 Billion CNY | 1.09% |
| 2018 FY | 5.24 Billion CNY | 7.99% |
| 2018 Q1 | 5.11 Billion CNY | 5.43% |
| 2018 Q2 | 4.87 Billion CNY | -4.74% |
| 2017 Q1 | 4.3 Billion CNY | 1.87% |
| 2017 FY | 4.85 Billion CNY | 14.93% |
| 2017 Q4 | 4.85 Billion CNY | 7.21% |
| 2017 Q3 | 4.52 Billion CNY | 7.03% |
| 2017 Q2 | 4.23 Billion CNY | -1.68% |
| 2016 Q2 | 3.12 Billion CNY | -7.88% |
| 2016 Q1 | 3.39 Billion CNY | 1.84% |
| 2016 FY | 4.22 Billion CNY | 26.74% |
| 2016 Q4 | 4.22 Billion CNY | 1.14% |
| 2016 Q3 | 4.17 Billion CNY | 33.58% |
| 2015 Q3 | 3.12 Billion CNY | -3.16% |
| 2015 Q2 | 3.22 Billion CNY | 37.78% |
| 2015 FY | 3.33 Billion CNY | 44.56% |
| 2015 Q1 | 2.34 Billion CNY | 1.56% |
| 2015 Q4 | 3.33 Billion CNY | 6.67% |
| 2014 Q1 | 2.01 Billion CNY | 1.9% |
| 2014 Q4 | 2.3 Billion CNY | 4.72% |
| 2014 Q3 | 2.2 Billion CNY | 2.46% |
| 2014 FY | 2.3 Billion CNY | 16.43% |
| 2014 Q2 | 2.14 Billion CNY | 6.5% |
| 2013 Q2 | 1.74 Billion CNY | 2.42% |
| 2013 Q3 | 1.79 Billion CNY | 2.94% |
| 2013 FY | 1.98 Billion CNY | 14.04% |
| 2013 Q1 | 1.69 Billion CNY | -2.14% |
| 2013 Q4 | 1.98 Billion CNY | 10.54% |
| 2012 Q3 | 1.64 Billion CNY | 3.18% |
| 2012 Q4 | 1.73 Billion CNY | 5.29% |
| 2012 FY | 1.73 Billion CNY | 10.66% |
| 2012 Q1 | 1.61 Billion CNY | 3.0% |
| 2012 Q2 | 1.59 Billion CNY | -1.1% |
| 2011 Q2 | 1.51 Billion CNY | -0.35% |
| 2011 Q4 | 1.56 Billion CNY | 3.17% |
| 2011 Q3 | 1.52 Billion CNY | 0.59% |
| 2011 FY | 1.56 Billion CNY | 5.91% |
| 2011 Q1 | 1.51 Billion CNY | 2.41% |
| 2010 Q2 | 1.39 Billion CNY | -0.23% |
| 2010 Q3 | 1.43 Billion CNY | 2.52% |
| 2010 Q1 | 1.39 Billion CNY | -0.37% |
| 2010 Q4 | 1.48 Billion CNY | 3.62% |
| 2010 FY | 1.48 Billion CNY | 5.6% |
| 2009 Q2 | 347.53 Million CNY | 0.0% |
| 2009 Q3 | 345.85 Million CNY | -0.48% |
| 2009 Q4 | 1.4 Billion CNY | 305.83% |
| 2009 FY | 1.4 Billion CNY | 345.7% |
| 2008 FY | 314.92 Million CNY | 5.77% |
| 2008 Q4 | 314.92 Million CNY | 0.0% |
| 2007 FY | 297.73 Million CNY | 2.09% |
| 2006 FY | 291.65 Million CNY | 0.0% |